Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: R. Ramesh who wrote (891)	5/5/1998 11:27:00 AM
From: Jake's mom	Respond to of 1476

Its a small number of patients, but thats generally the case for Phase II trial. Seems to have real promise. Might actually work in humans. Jake's mom (pediatrician, where we have lots of immunizations and lots of diarrhea. Will need Phase III before use in large scale, though)

To: R. Ramesh who wrote (891)	5/5/1998 1:02:00 PM
From: KZAP	Read Replies (1) \| Respond to of 1476

Sounded very promising to me. Who wants to get sick like that to test the medicine? Small number of test subjects is all that is needed. I feel they are on track. Stock price reflects investors confidence. I sent in my proxy today. I'm for the merger. Just look what drug development does to a stock. ENMD went ballistic yesterday. Today a day trader could make major bucks also. KZAP